-transparent.png){kind=logo}
The potential clinical utility of the radioreceptor assay for neuroleptics (NRRA) was examined. The NRRA was able to detect neuroleptic activity in blood specimens from patients receiving a variety of neuroleptic medications. For each medication, mean plasma neuroleptic activity was lower in patients showing a poor response to treatment than in those showing a good response. Because the range of plasma neuroleptic activities found was quite different from drug to drug, it appears that results obtained by the NRRA must be standarized for each drug.
Related Publications
B M Cohen, and
J F Lipinski, and
P Q Harris, and
H G Pope, and
M Friedman
March 1984,
The Journal of clinical psychiatry,
B M Cohen, and
J F Lipinski, and
P Q Harris, and
H G Pope, and
M Friedman
July 1979,
Psychiatry research,
B M Cohen, and
J F Lipinski, and
P Q Harris, and
H G Pope, and
M Friedman
January 1986,
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
B M Cohen, and
J F Lipinski, and
P Q Harris, and
H G Pope, and
M Friedman
October 1993,
Canadian journal of psychiatry. Revue canadienne de psychiatrie,
B M Cohen, and
J F Lipinski, and
P Q Harris, and
H G Pope, and
M Friedman
September 1985,
Radioisotopes,
B M Cohen, and
J F Lipinski, and
P Q Harris, and
H G Pope, and
M Friedman
January 1976,
Nihon rinsho. Japanese journal of clinical medicine,
B M Cohen, and
J F Lipinski, and
P Q Harris, and
H G Pope, and
M Friedman
October 1980,
Journal of clinical pharmacology,
B M Cohen, and
J F Lipinski, and
P Q Harris, and
H G Pope, and
M Friedman
January 1984,
European journal of respiratory diseases. Supplement,
B M Cohen, and
J F Lipinski, and
P Q Harris, and
H G Pope, and
M Friedman
February 1976,
The Journal of clinical endocrinology and metabolism,
B M Cohen, and
J F Lipinski, and
P Q Harris, and
H G Pope, and
M Friedman
October 1996,
Clinical biochemistry,
